期刊文献+

伊曲康唑治疗肝衰竭合并侵袭性肺部真菌感染患者的疗效和安全性分析 被引量:2

Efficacy and safety of itraconazole in the treatment of invasive fungal lung infection among patients with hepatic failure
原文传递
导出
摘要 目的评价伊曲康唑治疗肝衰竭合并侵袭性肺部真菌感染患者的疗效和安全性。方法回顾性分析伊曲康唑治疗肝衰竭合并侵袭性肺部真菌感染患者的有效性和安全性。治疗方法:静脉注射伊曲康唑0.2g静脉滴注q12h1天或者2天后改为伊曲康唑0.2g静脉滴注qd,疗程2—4周。结果共有16例患者符合人选标准和排除标准纳入本研究,男女比例为3:1。其中4例由白色念珠菌感染所造成,4例为热带念珠菌感染,8例为曲霉感染。临床结果:4例肝衰竭合并白色念珠菌感染患者,其中3例治愈出院,1例死于肝衰竭。4例肝衰竭合并热带假丝酵母感染患者,其中2例治愈出院,1例死于肺部感染,1例死于肝衰竭。8例肝衰竭合并肺曲菌病感染患者中,5例感染控制,其中2例治愈出院,2例接受肝移植,1例死于肝衰竭。3例肺部感染加重,死于呼吸衰竭。结论伊曲康唑治疗肝衰竭合并侵袭性肺部真菌感染安全有效,可以作为治疗肝衰竭合并侵袭性肺部真菌感染患者的选择。 Objective To evaluate the efficacy and safety of itraconazole in the treatment of invasive fungal infection among pa- tients with hepatic failure. Methods A retrospective study was conducted to assess the efficacy and safety of itraconazole in treating inva- sive fungal infection in patients with hepatic failure. Treatment protocol : intravenous itraconazole 0.2 g ql2h on Day 1 and Day 2, fol- lowed by 0.2 g iv qd for 2-4 weeks. Results A total of 16 patients were enrolled with a male to female ratio of 3 1, including four pa- tients with infection caused by Candida albicans, four with Candida tropicalis infection, and eight with Aspergillus infection. Clinical out- comes : of the four patients who suffered from hepatic failure and invasive Candida albicans infection, three patients were cured of fungal infection and discharged while one died from hepatic failure. Of the four patients who had Candida tropicalis infection, improvement was observed in two patients who were then safely discharged; one patients died from pulmonary infection and one died from hepatic failure. A- mong the eight patients who had pulmonary aspergillosis, infection was controlled in five patients, of whom, two patient was discharged and two received liver transplant later, one died from hepatic failure. Three patients had exacerbation of pulmonary infection and died from respiratory failure. Conclusion Itraconazole is a safe and effective treatment option for invasive fungal infection among patients with he- patic failure.
出处 《中国微生态学杂志》 CAS CSCD 2013年第8期946-948,共3页 Chinese Journal of Microecology
关键词 伊曲康唑 侵袭性真菌感染 肝衰竭 安全性 Itraconazole Invasive fungal infection Hepatic failure Safety
  • 相关文献

参考文献8

  • 1Erjavec Z, Kluin-Nelemans H, Verweij PE. Trends in invasive fungal infections, with emphasis on invasive aspergillosis [ J ]. Clin Microbiol Infect,2009,15(7) :625-633.
  • 2Bienvenu AL,Walter T,Boulez F,et al. Acute liver failure may lead to lethal pulmonary aspergillosis [ J ]. J Clin Gastroenterol, 2010,44 ( 8 ) : 593 -594.
  • 3Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 4重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966. 被引量:429
  • 5Smith JA, Kauffman CA. Recognition and prevention of nosocomial in- vasive fungal infections in the intensive care unit[ J]. Crit Care Med, 2010,38(8 Suppl) :S380-S387.
  • 6Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients : results of the Transplant-Associated Infection Surveillance Network (TRANSNET) [ J ]. Clin Infect Dis, 2010,50(8) :1101-1111.
  • 7Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients [ J ]. Transplant Infect Dis,2010,12(3 ) :220-229.
  • 8Girois SB, Chapuis F, Decullier E, et al. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis[ J ]. Europ J Clin Microbiol & Infect Dis,2006,25 (2) :138-149.

二级参考文献10

共引文献1243

同被引文献19

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部